Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
138.77
-4.29 (-3.00%)
Feb 11, 2026, 11:56 AM EST - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Filtration Products Revenue
-372.96M341.38M
Filtration Products Revenue Growth
-9.25%-31.16%
Chromatography Products Revenue
-122.81M126.63M
Chromatography Products Revenue Growth
--3.02%-3.84%
Process Analytics Products Revenue
-59.30M56.82M
Process Analytics Products Revenue Growth
-4.37%6.18%
Proteins Products Revenue
-74.43M103.46M
Proteins Products Revenue Growth
--28.07%-9.50%
Other Products Revenue
-4.68M3.69M
Other Products Revenue Growth
-26.87%-35.76%
Total Product Revenue
707.63M634.18M631.98M
Total Product Revenue Growth
11.58%0.35%-21.12%
Royalty and Other Revenue
264.00K261.00K383.00K
Royalty and Other Revenue Growth
1.15%-31.85%8.50%
Revenue (Total)
707.89M634.44M632.36M
Revenue (Total) Growth
11.58%0.33%-21.11%
Updated Oct 28, 2025. Data Source: Fiscal.ai.